Nucrest Pharma Private Limited

Nucrest Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24110MH2019PTC334133 Incorporated 09 December 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2025
₹71.97 Cr
▲ 21% YoY
Net profit · FY 2025
₹4.74 Cr
Net margin 6.6%
EBITDA · FY 2025
₹6.75 Cr
EBITDA margin 9.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹7.8 Cr
Satisfied ₹6.33 Cr
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings

About Nucrest Pharma Private Limited

Data last updated:

Nucrest Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 December 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2019PTC334133. Its GSTIN is 27AAGCN7862G1Z3 (Maharashtra).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Ashok Rupchand Panjwani and Vikram Ashok Panjwani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹71.97 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹4.74 Cr (net margin 6.6%) and EBITDA of ₹6.75 Cr (EBITDA margin 9.4%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years.

The company is associated with 1 brand: Nucrest. As per MCA filings, the company has open charges of ₹7.8 Cr and satisfied charges of ₹6.33 Cr on record. Court records list 27 cases involving the company, including 27 filed against it; 8 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹99 Lakh; the latest was in January 2021.

Nucrest Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0154561). For more details, the company can be reached via its website nucrest.in.

Company details

CIN U24110MH2019PTC334133
Registration Number 334133
Incorporation Date 09 December 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0154561
Key People
Ashok Rupchand Panjwani Director Vikram Ashok Panjwani Director

Recognitions & Rankings of Nucrest Pharma

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-18-0154561

Contact details

Nucrest Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is nucrest.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    nucrest.in
  • Registered Address
    Office No.2307 & 2308 Parinee L Shah, Industrialestateoffveeradesairoad, Mumbai, Maharashtra, India – 400053
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Nucrest Pharma Private Limited, buy the company report.

Comprehensive company report
Nucrest Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Nucrest Pharma operates one associated brand: Nucrest. Each brand links to its own profile.

BrandDescriptionWebsite
Nucrest
Distributes high-quality pharmaceutical products to healthcare providers.nucrest.in

Business activity

The main business activity of Nucrest Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Nucrest Pharma Private Limited, buy the company report.

Financials of Nucrest Pharma Private Limited

FY 2025 filings available

Nucrest Pharma Private Limited reported revenue of ₹71.97 Cr (up 21% YoY) for FY 2025.

Revenue · FY 2025
₹71.97 Cr ▲ 21%
Net profit · FY 2025
₹4.74 Cr margin 6.6%
EBITDA · FY 2025
₹6.75 Cr margin 9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 13%
5 years · compounded
▲ 336%

Revenue rose 21% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.75 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.74 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.4%
Net Profit Margin6.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nucrest Pharma Private Limited, buy the company report.

Board of directors of Nucrest Pharma Private Limited

Nucrest Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashok Rupchand PanjwaniDirector09 Dec 20196 Years 10 MonthsCurrent
Vikram Ashok PanjwaniDirector09 Dec 20196 Years 10 MonthsCurrent
View all directors

Auditor

Nucrest Pharma Private Limited is audited by B.N.KEDIA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B.N.KEDIA & CO.FY 2023001652N

Shareholding

The shareholding of Nucrest Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nucrest Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.8 Cr
Satisfied charges
₹6.33 Cr
Breakdown by lending institutions
Others₹7.80 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Jul 2025101129941Others₹5 CrOpen
17 Aug 2023100770734Others₹15.6 LakhOpen
31 Dec 2020100404745Others₹2.65 CrOpen
21 Mar 2025101076002Others₹72 LakhSatisfied
12 Mar 2025101070900Others₹22.5 LakhSatisfied

To see the full charge records of Nucrest Pharma Private Limited, buy the company report.

Total charge records: 11 View all charges

Deals & funding

Nucrest Pharma Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹99 Lakh; the latest was in January 2021.

Total deals
1
Funding round
1
Disclosed funding
₹99 Lakh

Deals on record (1 of 1)

WhenDealAmountParties
Jan 2021Funding round₹99 LakhInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nucrest Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Nucrest Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCN7862G1Z3MaharashtraActive15 Jun 2020

To see the full GST registrations and return filing status of Nucrest Pharma Private Limited, buy the company report.

Recent activity

Nucrest Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ashok Rupchand Panjwani was appointed as Director on 09 Dec 2019.

AGM
Nucrest Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 21 Mar 2025 via Charge ID 101076002 with Others was fully satisfied on 11 Aug 2025.
Charges
A charge registered on 12 Mar 2025 via Charge ID 101070900 with Others was fully satisfied on 11 Aug 2025.
Charges
A charge registered on 06 Mar 2025 via Charge ID 101070907 with Others was fully satisfied on 11 Aug 2025.
Charges
A charge registered on 05 Mar 2025 via Charge ID 101070909 with Others was fully satisfied on 11 Aug 2025.
Charges
A charge registered on 11 Mar 2025 via Charge ID 101070334 with Others was fully satisfied on 05 Aug 2025.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101129941 was registered on 22 Jul 2025.
Filing
Nucrest Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 27 Mar 2024 via Charge ID 100905129 with Others was fully satisfied on 28 Mar 2025.
Charges
A charge with Others amounted to Rs. 0.72 Cr with Charge ID 101076002 was registered on 21 Mar 2025.
Charges
A charge with Others of Rs. 2.65 Cr registered on 31 Dec 2020 with Charge ID 100404745 was modified on 17 Mar 2025.
Charges
A charge with Others amounted to Rs. 0.23 Cr with Charge ID 101070900 was registered on 12 Mar 2025.

13 earlier events are in the company report.

Frequently asked questions

Nucrest Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 December 2019 (7+ years old) and is registered under CIN U24110MH2019PTC334133.

Nucrest Pharma has 2 current directors:

The latest financial statements of Nucrest Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Nucrest Pharma is 27AAGCN7862G1Z3, registered in Maharashtra.

The CIN (Corporate Identification Number) of Nucrest Pharma is U24110MH2019PTC334133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nucrest Pharma has 27 court cases on record: 27 filed against it. 8 are pending.

Nucrest Pharma was incorporated on 09 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

Nucrest Pharma has 1 deal on record (1 funding round), with disclosed funding of ₹99 Lakh; the latest was in January 2021.

Ashok Rupchand Panjwani was appointed as Director on 09 Dec 2019. Vikram Ashok Panjwani was appointed as Director on 09 Dec 2019.

Yes, Nucrest Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0154561).